TechBooky AI Assistant
TechBooky AI Assistant
👋 Welcome to TechBooky AI Assistant

I can help with:
🔎 Tech News
🤖 AI Topics
💻 Gadgets
☁️ Cloud
✍️ Guest Posts
📢 Advertising
🔗 Backlinks
📩 Newsletter
  • AI Search
  • Cryptocurrency
  • Earnings
  • Enterprise
  • About TechBooky
  • Submit Article
  • Advertise With TechBooky
  • Contact Us
TechBooky
  • African
  • AI
  • Metaverse
  • Gadgets
  • Intelligence
  • AI Search
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
  • African
  • AI
  • Metaverse
  • Gadgets
  • Intelligence
  • AI Search
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
TechBooky
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Home Startups

54gene Unveils Its Branched Out African-Based Diagnostics Hub 7RiverLabs, Alongside More Sample Collection Centres In Nigeria.

54Gene is a Nigerian-based technology-powered diagnostic hub, while 7RiverLabs has other African countries as its marketplace

Paul Femi Balo by Paul Femi Balo
December 15, 2021
in Startups
Share on FacebookShare on Twitter
Share this story

Send it to someone who should read it.

f Facebook X X in LinkedIn wa WhatsApp tg Telegram @ Email

In Brief
  •   54Gene’s first subdivision diagnostics hub dubbed 7RiverLabs alongside new centres designated for health sample collection, Techbooky Africa writes.
  • 54Gene has reportedly influenced the healthcare sector with high-end technology to push diagnostics as a service across Africa.
  • 7RiverLabs establishment also serves its parent company’s fundamental objective that makes diagnostics advanced with ease.

 

54Gene’s first subdivision diagnostics hub dubbed 7RiverLabs alongside new centres designated for health sample collection, Techbooky Africa writes. 54Gene has reportedly influenced the healthcare sector with high-end technology to push diagnostics as a service across Africa. 7RiverLabs establishment also serves its parent company’s fundamental objective that makes diagnostics advanced with ease.

Just as 54Gene offers molecular diagnostics services that are available as third-party service to healthcare providers and or serving its patients directly, 7RiverLabs will continue its parent company’s reliable service with economic pricing. Remember 54Gene’s services is domineering the Nigerian healthcare marketplace — 7RiverLabs’ establishment is an expansion scheme aimed to encourage other potential patients and healthcare providers across Africa.

The new sample collection centres 54Gene stationed within the country will also create chances for employment, as well as other sample collection centres stationed across Africa. 54Gene serves as the bridge for Africans to experience advanced technology tackling chronic diseases and other health issues.

 

Also worth reading
Nigeria Startup Funding Hits $635 Million, but Four Deals Take Most of It AI Beats Doctors in Harvard ER Study, Showing Major Shift in Healthcare Nvidia Expands Open AI Models for Robotics and Healthcare Gates Foundation & OpenAI Partner to Advance AI-Driven Healthcare in Africa ChatGPT Health set for upgrade as OpenAI acquires Torch ChatGPT Now Available for Healthcare Providers, OpenAI Says

For context, the western world healthcare infrastructure is built with advanced technology that detects and prevents potential health issues. With standardized healthcare infrastructure, neither 54Gene nor its branched out 7RiverLabs diagnostics hub need not consult healthcare practitioners based overseas for clarified health analysis on chronic health issues via patients deposited test samples.

 

54Gene’s chief executive officer, Dr. Abasi Ene-Obong, and his boards of administrators confirmed Jude Uzonwanne’s appointment as 7RiverLabs ceremonial chief executive officer, while Jude continues to serve 54Gene as its chief business officer. Jude also confirmed 54Gene dubbed 7RiverLabs per the seven major rivers that flow through Africa.

Dr. Abasi also commended 7RiverLabs’ establishment that acknowledges the Nigerian Ministry of Health’s agenda to curb the mortality surge influenced by illegitimate diagnostics infrastructure revealing false health information. 7RiverLabs will also serve diagnostics hub that perform complex health test, viz: microbiology, infectious diseases, anatomic pathology, genetic sequencing, clinical chemistry, etc.

54Gene’s CEO assures 7RiverLabs healthcare service fee is tagged at an economic friendly rate when it becomes real-time accessible in 2022. As expected both 54Gene and 7RiverLabs will also serve as a bridge between third-party physicians communicating with their patients as a pair — starting with Nigeria, expanding across Africa.

Related Reading

More contextual TechBooky stories selected from tags, categories and article context.

  • FotoJet-2023-08-01T114040.319
    QED’s Equity Pool is Empowering Remedial Health in Nigeria
  • Wellahealth-Logo-1024x1024
    Health Tech Startup in Nigeria Hits 1.4b Naira Milestone
  • 59647364-bf73-46c2-97bb-f9ad37119907
    Nigeria's NSIA Awards $275,000 to Startups,…
  • accenture ookla
    Accenture Acquires Downdetector & Speedtest In A $1.2b Deal
  • nvidia1
    How Nvidia Contributed To The 2023 AI Odyssey
  • Access-to-Markets-2026-800x500
    Four i3 Deals Bring African Health Tech Closer to Patients
  • 1536x864_cmsv2_85cb6ed8-f81c-5f21-8cb1-78ee23597afe-9605926
    ChatGPT Now Available for Healthcare Providers, OpenAI Says
  • nhs_tech_provider_dxs_admits_breach_of_office_serv_edited_1766078164
    NHS England Tech Supplier Confirms Data Breach
Keep Reading Smarter

Search TechBooky with AI

Use TechBooky's AI Search to explore the context behind this story and related coverage across the site.

Try AI Search
More On This Topic
Startups
Follow TechBooky

Follow TechBooky for more technology stories and newsroom updates.

f Facebook X X in LinkedIn ig Instagram wa WhatsApp

Tags: 54gene7RiverLabshealthcareHubtechnology
Paul Femi Balo

Paul Femi Balo

Paul Femi Balo is the founder and publisher of TechBooky. He covers artificial intelligence, African technology, digital infrastructure, enterprise technology and the global digital economy.

Search TechBooky
Open TechBooky AI Search Try the AI Assistant

BROWSE BY CATEGORIES

Receive top tech news directly in your inbox

subscription from
Loading

Freshly Squeezed

  • Anthropic’s November IPO Could Raise $100B at $1.5T-$2T Valuation, Report Says October 27, 2026
  • OpenAI Says Its AI Disproved a Major Computing Hypothesis October 27, 2026
  • South Africa Fines FNB R1 Million Over Customer Data Failures October 27, 2026
  • DPI Closes $112M Nclude Fund, 93% From African Investors October 27, 2026
  • Dangote Refinery Is First to Deploy Honeywell Industrial AI October 27, 2026
  • Microsoft Voluntary Exit Offer Could Reach 60,000 Staff October 27, 2026
  • Anthropic Publicly Files for IPO as Claude Costs Face Scrutiny October 26, 2026
  • Meta Seeks Up to $95B in Equity to Fund AI Expansion October 26, 2026
  • Klump Shuts Down as Funding and Bank Delays Stall Nigerian BNPL October 26, 2026
  • Airtel Money Revenue Hits $830M in First Results Since London IPO October 26, 2026
  • US Campaigns Try to Shape AI Chatbot Answers to Voters, Reuters Reports October 26, 2026
  • TechBooky Intelligence Launches With a New Look at Africa’s Tech Economy October 26, 2026

Browse Archives

October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Sep    

Quick Links

  • About TechBooky
  • Advertise With TechBooky
  • Contact us
  • Submit Article
  • Privacy Policy
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
  • African
  • Artificial Intelligence
  • Gadgets
  • Metaverse
  • Tips
  • AI Search
  • Intelligence
  • About TechBooky
  • Advertise With TechBooky
  • Submit Article
  • Contact us

© 2025 Designed By TechBooky Elite

Discover more from TechBooky

Subscribe now to keep reading and get access to the full archive.

Continue reading

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.